Artiria Medical stands out in the neurovascular tools segment as one of very few startups focused specifically on guidewire navigation rather than thrombectomy devices, giving it a narrower competitive set but a clear procedural pain point. With FDA clearance, 50+ clinical cases, and Series A funding, it sits further along the commercialization curve than most neurotech startups at comparable scale.